Key result
Metabolic syndrome was independently associated with intracranial atherosclerosis in patients with stroke (p=0.005).
Why the study?
Is metabolic syndrome associated with intracranial atherosclerosis in patients with stroke?
Observational (n=512)
Is metabolic syndrome associated with intracranial atherosclerosis in patients with stroke?
Answers are grounded in this paper and cite their sources.
Metabolic syndrome is independently associated with intracranial atherosclerosis in stroke patients, suggesting metabolic management may be key for prevention.
To investigate the impact of metabolic syndrome (MetSD) on the development of intracranial atherosclerotic stroke, the authors evaluated the components of the MetSD in 512 patients with stroke. The MetSD was observed most frequently in patients with intracranial atherosclerosis (p = 0.007). In multiple regression analysis, the MetSD, but not conventional risk factors, was independently associated with intracranial atherosclerosis (p = 0.005). The results suggest that treatment of metabolic abnormalities may be an important prevention strategy for intracranial atherosclerosis.
No takes yet. Share an insight, caveat, or question.
Bang et al. (2005) conducted an observational in Stroke (n=512). Metabolic syndrome was evaluated on Intracranial atherosclerosis (p=0.005). Metabolic syndrome was independently associated with intracranial atherosclerosis in patients with stroke (p=0.005).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: